Digital radiography developer Swissray International has signed on Elscint as a distributor of Swissray’s AddOn-Multi-System in several countries around the world. The agreement does not apply to the U.S., however, where Swissray is setting up its
Digital radiography developer Swissray International has signed on Elscint as a distributor of Swissrays AddOn-Multi-System in several countries around the world. The agreement does not apply to the U.S., however, where Swissray is setting up its own distribution network.
Under the terms of the deal, Elscint will serve as Swissrays exclusive distributor in the U.K., Canada, France, Italy, Spain, Belgium, Luxembourg, Poland, Hungary, Ukraine, Israel, South Africa, Mexico, and Brazil. The agreement is an important milestone for Swissray in its efforts to build a distribution network for its technology. Elscint has substantial distribution resources available at its command, especially in Europe, and the deal should bring Swissray added credibility in the global market.
The relationship will complement Swissrays own direct sales efforts in the U.S., Switzerland, and Germany, said Ueli Laupper, vice president of international sales and marketing for New York City-based Swissray. In the U.S., the company sells AddOn-Multi-System direct in Texas, New York City, Chicago, Los Angeles, and San Francisco. Swissray has distributors serving other regions of the country and plans to have a complete distribution network in place by the end of the September, Laupper said.
For Elscint, the Swissray deal marks the return of the Haifa, Israel-based company to the radiography market. The firm departed the sector when it shut down its Xonics subsidiary more than 10 years ago (SCAN 7/8/87 and 11/22/89). The agreement allows Elscint to offer its customers comprehensive digital radiology department solutions, and complements the firms PACS and general connectivity offerings, according to Dov Maor, Elscints vice president for technology and manager of the companys connectivity business unit. Elscint offers connectivity software developed by Algotec Systems of Raanana, Israel, and also maintains a sales and marketing agreement with Agfa for that companys Impax PACS product line.
Adjunctive AI Powered Tool for Tuberculosis Detection Gets FDA's Breakthrough Device Designation
February 5th 2024With reported increases in tuberculosis cases after the COVID-19 pandemic, the qSpot-TB adjunctive artificial intelligence (AI) device may facilitate improved diagnosis of the disease on chest X-rays.
3D Hip CT AI Model Bolsters Future Fracture Risk Assessment for Patients with Hip Fractures
January 30th 2024Employing reconstructed radiographs from 3D hip CT scans, a deep learning model demonstrated a higher concordance index (C index) and higher two- and three-year AUCs than multiple imaging models and three clinical models for predicting subsequent fracture risk in patients with hip fractures.